- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03252704
Post-prandial Glycemic Response to Fiber in Healthy Adults
August 16, 2017 updated by: Ingredion Incorporated
Post-prandial Glucose and Insulin Response to High-fiber Muffin Top Containing Resistant Starch in Healthy Adults
This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The fiber administered in this trial is a resistant starch type 4 derived from high-amylose maize starch.
This product is high in dietary fiber (70% total dietary fiber (TDF), AOAC 2009.01 method) and can be used in a variety of bakery applications.
The objective of this study was to evaluate the post-prandial blood glucose and insulin responses of healthy adults (n=28) after consuming a muffin top made with resistant starch or control muffin top, in a randomized, double-blind, crossover study.
The muffin tops were matched for total weight, total carbohydrate, sugars, protein, and fat.
During each 24-hour study period, subjects consumed a standard evening meal, fasted for 12 hours, and arrived at the study clinic the following morning.
Serum glucose, serum insulin, and capillary glucose were measured after muffin top consumption.
The subjects completed a seven day washout between treatments.
Study Type
Interventional
Enrollment (Actual)
28
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years of age or older,
- BMI 18.0-29.9 kg/m2,
- fasting glucose ≤ 6.0 mmol/L;
- if female, not of childbearing potential (e.g. taking oral contraceptives, past hysterectomy)
Exclusion Criteria:
- diagnosed metabolic or chronic diseases (e.g. type-2 diabetes);
- cancer diagnosis or treatment within 5 years;
- gastrointestinal problems;
- bowel cleansing during prior week;
- current medications to control blood glucose;
- current medications to control blood cholesterol ;
- current medications to control blood pressure;
- smoker;
- use of medical marijuana;
- alcohol or drug abuse treatment in past 12 months;
- allergy or sensitivity to study products;
- blood donation in prior 2 months;
- if female, currently pregnant, currently breastfeeding, or planning to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High fiber - low fiber
Treatment order described in arm title, resistant starch (high fiber muffin top) - conventional flour (low fiber muffin top)
|
Muffin top contained 11 g of fiber per portion
Muffin top contained 1 g of fiber per portion
|
|
Experimental: low fiber - high fiber
Treatment order described in arm title, conventional flour (low fiber muffin top)- resistant starch (high fiber muffin top)
|
Muffin top contained 11 g of fiber per portion
Muffin top contained 1 g of fiber per portion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood glucose response
Time Frame: 0-4 hours after consumption
|
IV and capillary
|
0-4 hours after consumption
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood insulin response
Time Frame: 0-4 hours after consumption
|
IV
|
0-4 hours after consumption
|
|
Breath hydrogen response
Time Frame: 0-24 hours after consumption
|
Expired air
|
0-24 hours after consumption
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tetyana Pelipyagina, MD, KGK Synergize
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 31, 2016
Primary Completion (Actual)
October 31, 2016
Study Completion (Actual)
October 31, 2016
Study Registration Dates
First Submitted
August 14, 2017
First Submitted That Met QC Criteria
August 14, 2017
First Posted (Actual)
August 17, 2017
Study Record Updates
Last Update Posted (Actual)
August 21, 2017
Last Update Submitted That Met QC Criteria
August 16, 2017
Last Verified
August 1, 2017
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 16AFHI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose, Low Blood
-
Wageningen University and ResearchCompletedGlucose, Low Blood | Glucose, High BloodNetherlands
-
Izmir Bakircay UniversityEge UniversityCompletedBlood Glucose, LowTurkey
-
Matthew GroutCompletedMood | Cognitive Performance | Glucose, Low Blood | Glucose, High BloodUnited Kingdom
-
Matthew GroutCompletedDiet Modification | Mood | Glucose, Low Blood | Glucose, High Blood
-
University of ViennaCompletedHunger | Blood Glucose, LowAustria
-
Weizmann Institute of ScienceCompletedGlucose Intolerance | Glucose, Low Blood | Glucose, High BloodIsrael
-
Coombe Women and Infants University HospitalRecruitingFasting | Glucose, Low Blood | Cesarean Delivery Affecting FetusIreland
-
KK Women's and Children's HospitalActxa Pte LtdCompletedBlood Glucose, High | Blood Glucose, LowSingapore
-
Shaheed Benazir Bhutto University Sheringal Dir...Khyber Medical University PeshawarCompletedHypoglycemia | Blood Glucose, LowPakistan
-
Dose Safety Inc.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Benaroya...SuspendedGlucose, Low Blood | Glucose, High BloodUnited States
Clinical Trials on resistant starch (high fiber muffin top)
-
University of MinnesotaTate and Lyle Ingredients FranceCompleted
-
Midwest Center for Metabolic and Cardiovascular...General MillsCompletedWeight Loss | Gastrointestinal Symptoms | GLP-1United States
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingCognitive Impairment | Cognitive Decline | Genetic Risk Factors | Diet Interventions | Obesity &Amp; OverweightChina
-
Mondelēz International, Inc.Centre de Recherche en Nutrition Humaine Rhone-Alpe; Unite MetaGenoPolis INRAERecruiting
-
Midwest Center for Metabolic and Cardiovascular...Alliance for Potato Research and EducationCompletedInsulin Sensitivity | Lipid Metabolism | Potato | Resistant StarchUnited States
-
Springfield CollegeCompletedChronic Kidney DiseasesUnited States
-
Children's Hospital of Eastern OntarioActive, not recruitingInflammatory Bowel Diseases | Crohn DiseaseCanada
-
Children's Hospital of Eastern OntarioActive, not recruitingInflammatory Bowel Diseases | Crohn Disease | Ulcerative ColitisCanada